Trial Profile
Prospective pilot study evaluating the correlation between NPC1L1 gene polymorphism and clinical outcome of ezetimibe therapy in Chilean hypercholesterolemic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics; Therapeutic Use
- 04 Jan 2016 New trial record